Ethos Technologies Inc. - Class A (LIFE) SEC filings
LIFE SEC filings moved a median of -1.77% by the close. LIFE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the LIFE overview →
18 measured LIFE SEC filing events.
Where these LIFE SEC filings landedvs 12 measured LIFE SEC filing reactions
| Middle 50% of LIFE SEC filing reactions | -2.86% to +1.50% |
|---|---|
| Median reaction (to close) | -1.77% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 LIFE SEC filing events with a measured close landed between -2.86% and +1.50%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q aTYR PHARMA INC For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K aTYR PHARMA INC For: Nov 07 | SEC filing · Form 8-K | — | — | |
| Form 10-Q aTYR PHARMA INC For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Form 8-K aTYR PHARMA INC For: Aug 13 | SEC filing · Form 8-K | — | — | |
| Form S-8 aTYR PHARMA INC | SEC filing · Form S-8 | — | — | |
| Form 8-K aTYR PHARMA INC For: Jul 22 | SEC filing · Form 8-K | — | — | |
| Form 8-K aTYR PHARMA INC For: May 22 | SEC filing · Form 8-K | +0.59% | +4.14% | |
| Form 10-Q aTYR PHARMA INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.63% | |
| Form 8-K aTYR PHARMA INC For: May 02 | SEC filing · Form 8-K | +0.00% | +0.63% | |
| Form ARS aTYR PHARMA INC For: Dec 31 | SEC filing · Form ARS | +1.06% | -2.66% | |
| Form DEF 14A aTYR PHARMA INC For: May 22 | SEC filing · Form DEF | +1.06% | -2.66% | |
| Form DEFA14A aTYR PHARMA INC | SEC filing · Form DEFA14A | +1.06% | -2.66% | |
| Form 10-K aTYR PHARMA INC For: Dec 31 | SEC filing · Form 10-K | +6.79% | +22.84% | |
| Form 8-K aTYR PHARMA INC For: Mar 14 | SEC filing · Form 8-K | +6.79% | +22.84% | |
| Form EFFECT aTYR PHARMA INC | SEC filing · Form EFFECT | +0.87% | -0.87% | |
| Form 10-Q aTYR PHARMA INC For: Sep 30 | SEC filing · Form 10-Q | -1.72% | -3.45% | |
| Form 8-K aTYR PHARMA INC For: Nov 09 | SEC filing · Form 8-K | -1.72% | -3.45% | |
| Form S-3 aTYR PHARMA INC | SEC filing · Form S-3 | -1.72% | -3.45% |
Keep exploring
More LIFE: earnings → · analyst actions → · LIFE overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Intercept Pharmaceuticals, Inc. (ICPT) | 83 | +0.09% | 68% |
| COLOPLAST AS SP/ADR (CLPBY) | 82 | +0.13% | 59% |
| BASILEA PHARM AG AKT SHS (BPMUF) | 81 | 0.00% | 8% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.